Watch Ticker

Halozyme Therapeutics, Inc.

Go to Halozyme Therapeutics, Inc. Website

$63.25

3.26 (5.43%)

Live

Previous Close

$59.99

Day Range

$59.38 - $61.0499

Previous Day Range

$58.675 - $60.07

Market Cap

$7.3 billion USD

Day Vol.

3.2 million

Previous Day Vol.

1.1 million

Currency

USD

Primary Exchange

Nasdaq

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Acumen Pharmaceuticals - Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025

Acumen Pharmaceuticals will report Q2 2025 financial results on August 12, 2025, and host a conference call to provide a business and financial update, focusing on their Alzheimer's disease therapeutic candidate sabirnetug.

Related tickers: ABOS, HALO.

Read Full Article

N/A - argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy

argenx announced FDA approval of a new self-injection option for VYVGART Hytrulo, providing patients with generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy more flexibility and independence in their treatment.

Related tickers: ARGX, HALO.

Read Full Article

Trending Tickers

Please sign in to view